IPP Bureau
HMD Foundation donates iLAB unit to Amrita Hospital Faridabad
By IPP Bureau - July 08, 2023
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Cytel acquires French group stève consultants to expand real-world analytics capabilities
By IPP Bureau - July 08, 2023
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course
By IPP Bureau - July 08, 2023
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Dabur India expects 10%+ consolidated growth in Q1 FY24
By IPP Bureau - July 07, 2023
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Aarti Drugs bags Pharmexcil Outstanding Exports Awards 2021-22
By IPP Bureau - July 07, 2023
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Aster DM Healthcare increases stake in Malabar Institute of Medical Sciences
By IPP Bureau - July 07, 2023
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
GE HealthCare partners with Elekta to expand access to precision radiation therapy solutions in India
By IPP Bureau - July 07, 2023
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
PrecisionLife Licenses University of Oxford data to discover personalised treatments for endometriosis patients
By IPP Bureau - July 07, 2023
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Alkem forays into ophthalmology with launch of eye care products
By IPP Bureau - July 07, 2023
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Croda completes acquisition of Solus Biotech
By IPP Bureau - July 06, 2023
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Syngene to acquire multi-modal facility from Stelis Biopharma
By IPP Bureau - July 05, 2023
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Lupin receives tentative approval from USFDA for Dolutegravir Tablets for oral suspension
By IPP Bureau - July 05, 2023
Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
By IPP Bureau - July 05, 2023
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
CARE reaffirms A+ rating to IOL Chemicals and Pharmaceuticals
By IPP Bureau - July 05, 2023
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Cipla bags sustainable companies rankings for 2022-23
By IPP Bureau - July 05, 2023
Cipla has a robust governance model focused on sustainability
